Kenneth H. Louie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kenneth H. Louie has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Doris D. Wang
Department of Neurological Surgery, University of California, San Francisco, California
11 shared publications Jacob H. Marks
Department of Neurological Surgery, University California, San Francisco, San Francisco, CA, USA
5 shared publicationsHamid Fekri Azgomi
Department of Neurological Surgery, University of California
4 shared publicationsJannine P. Balakid
Department of Neurological Surgery, University of California, San Francisco, CA, USA
4 shared publications- Hamid Fekri Azgomi
Department of Neurological Surgery, University California, San Francisco, San Francisco, CA, USA
3 shared publications - Philip A. Starr
Department of Neurological Surgery, University of California, San Francisco, San Francisco, USA
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 15 June 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (8) , 2803-2814
Adaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial
A randomized crossover study of five patients with Parkinson’s disease (PD) demonstrates that gait-synchronized adaptive deep brain stimulation is feasible and safe, and reduces falls compared with continuous stimulation. Gait dysfunction in PD is a major source of disability and is often insufficiently treated by continuous deep brain stimulation (cDBS). Although adaptive DBS (aDBS) has shown efficacy for other motor symptoms using β-based, state-driven neural signals, gait is a dynamic, cyclical behavior that may require temporally precise modulation. Here we evaluated a behavior-contingent aDBS approach that synchronizes stimulation to gait phase. We reported a single-center, blinded, randomized, crossover study evaluating the feasibility of identifying patient-specific biomarkers to drive aDBS. The primary outcome was feasibility of successful identification of gait-phase biomarkers to implement aDBS. Five participants with PD undergoing pallidal DBS and subdural electrode paddle implantation were enrolled. We successfully identified personalized gait-phase biomarkers from cortical or pallidal field potentials in all five patients and embedded them into a bidirectional neurostimulator. During acute in-clinic testing, aDBS improved step variability and step symmetry versus cDBS. Three participants subsequently completed a double-blinded, multi-day crossover phase. In this setting, aDBS maintained general motor symptom control, reduced falls and yielded patient-specific gait improvements. No adverse events occurred and aDBS was well tolerated. These findings establish the feasibility of biomarker-driven, movement-synchronized neuromodulation and support the development of a larger randomized trial to determine clinical efficacy. ClinicalTrial.gov registration: NCT04675398 .
- 15 June 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (8) , 2803-2814
Top Cited PapersOpen AccessAdaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial
A randomized crossover study of five patients with Parkinson’s disease (PD) demonstrates that gait-synchronized adaptive deep brain stimulation is feasible and safe, and reduces falls compared with continuous stimulation. Gait dysfunction in PD is a major source of disability and is often insufficiently treated by continuous deep brain stimulation (cDBS). Although adaptive DBS (aDBS) has shown efficacy for other motor symptoms using β-based, state-driven neural signals, gait is a dynamic, cyclical behavior that may require temporally precise modulation. Here we evaluated a behavior-contingent aDBS approach that synchronizes stimulation to gait phase. We reported a single-center, blinded, randomized, crossover study evaluating the feasibility of identifying patient-specific biomarkers to drive aDBS. The primary outcome was feasibility of successful identification of gait-phase biomarkers to implement aDBS. Five participants with PD undergoing pallidal DBS and subdural electrode paddle implantation were enrolled. We successfully identified personalized gait-phase biomarkers from cortical or pallidal field potentials in all five patients and embedded them into a bidirectional neurostimulator. During acute in-clinic testing, aDBS improved step variability and step symmetry versus cDBS. Three participants subsequently completed a double-blinded, multi-day crossover phase. In this setting, aDBS maintained general motor symptom control, reduced falls and yielded patient-specific gait improvements. No adverse events occurred and aDBS was well tolerated. These findings establish the feasibility of biomarker-driven, movement-synchronized neuromodulation and support the development of a larger randomized trial to determine clinical efficacy. ClinicalTrial.gov registration: NCT04675398 .
- Open Access
- 13 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eadz4733
At-home movement state classification using totally implantable cortical-basal ganglia neural interface
Decoding human movement from invasive neural signals has traditionally relied on complex machine learning algorithms using data collected from short-term laboratory tasks, limiting understanding of brain function during natural behavior and hindering development of clinically viable closed-loop neuromodulation. Here, we demonstrate the first in-human, at-home classification of a specific movement state—walking—using a fully implantable, bidirectional neurostimulator. In four individuals with Parkinson’s disease, we recorded chronic motor cortex and globus pallidus activity synchronized with wearable kinematic data across over 80 hours of unsupervised daily activity. We identified highly predictive personalized spectral biomarkers of gait and validated their performance. Critically, we showed that these biomarkers could drive real-time movement state classification using the neurostimulator’s embedded linear discriminant classifier, satisfying device-level constraints for closed-loop stimulation. Our results establish a previously unidentified pipeline for real-world neural decoding and scalable framework for personalized adaptive neuromodulation, expanding the translational reach of implantable brain-computer interfaces.
- 13 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eadz4733
Open AccessAt-home movement state classification using totally implantable cortical-basal ganglia neural interface
Decoding human movement from invasive neural signals has traditionally relied on complex machine learning algorithms using data collected from short-term laboratory tasks, limiting understanding of brain function during natural behavior and hindering development of clinically viable closed-loop neuromodulation. Here, we demonstrate the first in-human, at-home classification of a specific movement state—walking—using a fully implantable, bidirectional neurostimulator. In four individuals with Parkinson’s disease, we recorded chronic motor cortex and globus pallidus activity synchronized with wearable kinematic data across over 80 hours of unsupervised daily activity. We identified highly predictive personalized spectral biomarkers of gait and validated their performance. Critically, we showed that these biomarkers could drive real-time movement state classification using the neurostimulator’s embedded linear discriminant classifier, satisfying device-level constraints for closed-loop stimulation. Our results establish a previously unidentified pipeline for real-world neural decoding and scalable framework for personalized adaptive neuromodulation, expanding the translational reach of implantable brain-computer interfaces.
- Open Access
Cortico-Pallidal Beta Dynamics Underlie Impaired Turning in Parkinson’s Disease
Turning while walking is one of the most common yet complex human movements, and it is frequently impaired in Parkinson’s disease (PD), leading to falls and loss of independence. The neural mechanisms underlying this difficulty remain unclear. Using chronically implanted devices that simultaneously record and stimulate the brain, we measured activity in the motor cortex and basal ganglia of individuals with PD during natural walking and turning. Successful turns were marked by reduced beta-band activity and flexible communication between cortical and pallidal regions, whereas impaired turns showed excessive beta synchrony that rigidly constrained movement. Medication and deep brain stimulation improved turning through distinct circuit mechanisms, dopamine suppressing abnormal pallidal beta activity and its communication with the cortex, and stimulation restoring cortical flexibility. These findings reveal how dynamic cortical–basal ganglia interactions enable complex movement and establish circuit targets for adaptive brain stimulation to reduce falls in PD.
Open AccessCortico-Pallidal Beta Dynamics Underlie Impaired Turning in Parkinson’s Disease
Turning while walking is one of the most common yet complex human movements, and it is frequently impaired in Parkinson’s disease (PD), leading to falls and loss of independence. The neural mechanisms underlying this difficulty remain unclear. Using chronically implanted devices that simultaneously record and stimulate the brain, we measured activity in the motor cortex and basal ganglia of individuals with PD during natural walking and turning. Successful turns were marked by reduced beta-band activity and flexible communication between cortical and pallidal regions, whereas impaired turns showed excessive beta synchrony that rigidly constrained movement. Medication and deep brain stimulation improved turning through distinct circuit mechanisms, dopamine suppressing abnormal pallidal beta activity and its communication with the cortex, and stimulation restoring cortical flexibility. These findings reveal how dynamic cortical–basal ganglia interactions enable complex movement and establish circuit targets for adaptive brain stimulation to reduce falls in PD.
- Open Access
Adaptive deep brain stimulation timed to gait phase improves walking in Parkinson’s disease
Gait dysfunction in Parkinson’s disease (PD) is a major source of disability and is often resistant to traditional deep brain stimulation (DBS). Here, we report a novel neuromodulation paradigm, gait-phase-synchronized adaptive DBS (aDBS), that dynamically modulates stimulation amplitude during contralateral leg swing. In five individuals with PD, we identified personalized neural biomarkers of gait phase from cortical and pallidal field potentials and embedded them into a chronically implanted bidirectional neurostimulator. These biomarkers, derived via a data-driven search, enabled real-time detection of swing phase and sub-second modulation of stimulation amplitude. Acute in-clinic testing showed that aDBS significantly reduced gait variability and improved bilateral symmetry compared to clinically optimized continuous DBS. In a double-blinded, multi-day crossover study, gait-phase-synchronized aDBS was well-tolerated, maintained general motor symptom control, and reduced falls and improved other gait metrics. These findings establish the feasibility of biomarker-driven, movement-synchronized neuromodulation and offer a promising strategy to restore dynamic motor control in PD.
Open AccessAdaptive deep brain stimulation timed to gait phase improves walking in Parkinson’s disease
Gait dysfunction in Parkinson’s disease (PD) is a major source of disability and is often resistant to traditional deep brain stimulation (DBS). Here, we report a novel neuromodulation paradigm, gait-phase-synchronized adaptive DBS (aDBS), that dynamically modulates stimulation amplitude during contralateral leg swing. In five individuals with PD, we identified personalized neural biomarkers of gait phase from cortical and pallidal field potentials and embedded them into a chronically implanted bidirectional neurostimulator. These biomarkers, derived via a data-driven search, enabled real-time detection of swing phase and sub-second modulation of stimulation amplitude. Acute in-clinic testing showed that aDBS significantly reduced gait variability and improved bilateral symmetry compared to clinically optimized continuous DBS. In a double-blinded, multi-day crossover study, gait-phase-synchronized aDBS was well-tolerated, maintained general motor symptom control, and reduced falls and improved other gait metrics. These findings establish the feasibility of biomarker-driven, movement-synchronized neuromodulation and offer a promising strategy to restore dynamic motor control in PD.
- Open Access
- 12 March 2025
- Published by Springer Nature in Research Square
At-Home Movement State Classification Using Totally Implantable Bidirectional Cortical-Basal Ganglia Neural Interface
Movement decoding from invasive human recordings typically relies on a distributed system employing advanced machine learning algorithms programmed into an external computer for state classification. These brain-computer interfaces are limited to short-term studies in laboratory settings that may not reflect behavior and neural states in the real world. The development of implantable devices with sensing capabilities is revolutionizing the study and treatment of brain circuits. However, it is unknown whether these devices can decode natural movement state from recorded neural activity or accurately classify states in real-time using on-board algorithms. Here, using a totally implanted sensing-enabled neurostimulator to perform long-term, at-home recordings from the motor cortex and pallidum of four subjects with Parkinson’s disease, we successfully identified highly sensitive and specific personalized signatures of gait state, as determined by wearable sensors. Additionally, we demonstrated the feasibility of using at-home data to generate biomarkers compatible with the classifier embedded on-board the neurostimulator. These findings offer a pipeline for ecologically valid movement biomarker identification that can advance therapy across a variety of diseases.
- 12 March 2025
- Published by Springer Nature in Research Square
Open AccessAt-Home Movement State Classification Using Totally Implantable Bidirectional Cortical-Basal Ganglia Neural Interface
Movement decoding from invasive human recordings typically relies on a distributed system employing advanced machine learning algorithms programmed into an external computer for state classification. These brain-computer interfaces are limited to short-term studies in laboratory settings that may not reflect behavior and neural states in the real world. The development of implantable devices with sensing capabilities is revolutionizing the study and treatment of brain circuits. However, it is unknown whether these devices can decode natural movement state from recorded neural activity or accurately classify states in real-time using on-board algorithms. Here, using a totally implanted sensing-enabled neurostimulator to perform long-term, at-home recordings from the motor cortex and pallidum of four subjects with Parkinson’s disease, we successfully identified highly sensitive and specific personalized signatures of gait state, as determined by wearable sensors. Additionally, we demonstrated the feasibility of using at-home data to generate biomarkers compatible with the classifier embedded on-board the neurostimulator. These findings offer a pipeline for ecologically valid movement biomarker identification that can advance therapy across a variety of diseases.
- Open Access
At-Home Movement State Classification Using Totally Implantable Bidirectional Cortical-Basal Ganglia Neural Interface
Movement decoding from invasive human recordings typically relies on a distributed system employing advanced machine learning algorithms programmed into an external computer for state classification. These brain-computer interfaces are limited to short-term studies in laboratory settings that may not reflect behavior and neural states in the real world. The development of implantable devices with sensing capabilities is revolutionizing the study and treatment of brain circuits. However, it is unknown whether these devices can decode natural movement state from recorded neural activity or accurately classify states in real-time using onboard algorithms. Here, using a totally implanted bidirectional neurostimulator to perform long-term, at-home recordings from the motor cortex and pallidum of four subjects with Parkinson’s disease, we successfully identified highly sensitive and specific personalized signatures of gait state, as determined by wearable sensors. Additionally, we demonstrated the feasibility of using these neural biomarkers to drive adaptive stimulation with the classifier embedded onboard the neurostimulator. These findings offer a pipeline for ecologically valid movement biomarker identification that can advance therapy across a variety of diseases.
Open AccessAt-Home Movement State Classification Using Totally Implantable Bidirectional Cortical-Basal Ganglia Neural Interface
Movement decoding from invasive human recordings typically relies on a distributed system employing advanced machine learning algorithms programmed into an external computer for state classification. These brain-computer interfaces are limited to short-term studies in laboratory settings that may not reflect behavior and neural states in the real world. The development of implantable devices with sensing capabilities is revolutionizing the study and treatment of brain circuits. However, it is unknown whether these devices can decode natural movement state from recorded neural activity or accurately classify states in real-time using onboard algorithms. Here, using a totally implanted bidirectional neurostimulator to perform long-term, at-home recordings from the motor cortex and pallidum of four subjects with Parkinson’s disease, we successfully identified highly sensitive and specific personalized signatures of gait state, as determined by wearable sensors. Additionally, we demonstrated the feasibility of using these neural biomarkers to drive adaptive stimulation with the classifier embedded onboard the neurostimulator. These findings offer a pipeline for ecologically valid movement biomarker identification that can advance therapy across a variety of diseases.
- Open Access
Pallidal and motor cortical interactions determine gait initiation dynamics in Parkinson’s disease
Gait initiation is a fundamental human task, requiring one or more anticipatory postural adjustments (APA) prior to stepping. Deviations in amplitude and timing of APAs exist in Parkinson’s disease (PD), causing dysfunctional postural control which increases the risk of falls. The motor cortex and basal ganglia have been implicated in the regulation of postural control, however, their dynamics during gait initiation, relationship to APA metrics, and response to pharmacotherapy such as levodopa are unknown. To address these questions, we streamed electrocorticography (ECoG) potentials from the premotor and primary motor cortices, as well as local field potentials (LFPs) from the globus pallidus in five people with PD exhibiting gait and balance dysfunction during a cued gait initiation task. Amplitude and timing of APA were evaluated with force plates and synchronized to the neural data. Subjects performed gait initiation trials under ON and LOW levodopa conditions to assess effects of medication on APA metrics and underlying neural dynamics. All subjects demonstrated pallidal and cortical oscillatory changes during different phases of gait initiation. Grouped analysis revealed that from quiet standing to the first foot step, pallidal beta power showed stepwise decrease and broadband gamma power increases, whereas cortical potentials showed low frequency (theta, alpha, beta) power decrease during gait initiation, regardless of medication state. The pallidum and motor cortices also became increasingly coherent during gait initiation compared to quiet standing prior to APA onset. Using linear mixed models, we found that while pallidal gamma powers are predictive of APA scaling, pallidal-cortical coherence (theta, alpha, beta) and premotor-M1 gamma coherence are predictive of APA timing. Our study is the first detailed characterization of basal-ganglia cortical circuit dynamics during human gait initiation. We identified significant pallidal motor cortical power and coherence changes that underlie the amplitude and timing of APA which appear to be independent of medication states of the study subjects. Our results provide evidence for a model where synchronized premotor and motor cortical activities transiently couple with the globus pallidus to regulate the timing of postural responses, and local pallidal activity regulate the amplitude of postural changes during gait initiation. It suggests that abnormal pallidal outflow and synchronization between the pallidum and motor cortices may be a pathophysiological mechanism underlying disordered postural response in Parkinson’s disease.
Open AccessPallidal and motor cortical interactions determine gait initiation dynamics in Parkinson’s disease
Gait initiation is a fundamental human task, requiring one or more anticipatory postural adjustments (APA) prior to stepping. Deviations in amplitude and timing of APAs exist in Parkinson’s disease (PD), causing dysfunctional postural control which increases the risk of falls. The motor cortex and basal ganglia have been implicated in the regulation of postural control, however, their dynamics during gait initiation, relationship to APA metrics, and response to pharmacotherapy such as levodopa are unknown. To address these questions, we streamed electrocorticography (ECoG) potentials from the premotor and primary motor cortices, as well as local field potentials (LFPs) from the globus pallidus in five people with PD exhibiting gait and balance dysfunction during a cued gait initiation task. Amplitude and timing of APA were evaluated with force plates and synchronized to the neural data. Subjects performed gait initiation trials under ON and LOW levodopa conditions to assess effects of medication on APA metrics and underlying neural dynamics. All subjects demonstrated pallidal and cortical oscillatory changes during different phases of gait initiation. Grouped analysis revealed that from quiet standing to the first foot step, pallidal beta power showed stepwise decrease and broadband gamma power increases, whereas cortical potentials showed low frequency (theta, alpha, beta) power decrease during gait initiation, regardless of medication state. The pallidum and motor cortices also became increasingly coherent during gait initiation compared to quiet standing prior to APA onset. Using linear mixed models, we found that while pallidal gamma powers are predictive of APA scaling, pallidal-cortical coherence (theta, alpha, beta) and premotor-M1 gamma coherence are predictive of APA timing. Our study is the first detailed characterization of basal-ganglia cortical circuit dynamics during human gait initiation. We identified significant pallidal motor cortical power and coherence changes that underlie the amplitude and timing of APA which appear to be independent of medication states of the study subjects. Our results provide evidence for a model where synchronized premotor and motor cortical activities transiently couple with the globus pallidus to regulate the timing of postural responses, and local pallidal activity regulate the amplitude of postural changes during gait initiation. It suggests that abnormal pallidal outflow and synchronization between the pallidum and motor cortices may be a pathophysiological mechanism underlying disordered postural response in Parkinson’s disease.
- Open Access
Motor learning leverages coordinated low-frequency cortico-basal ganglia activity to optimize motor preparation in humans with Parkinson’s Disease
Learning dexterous motor sequences is crucial to autonomy and quality of life but can be altered in Parkinson’s Disease (PD). Learning involves optimizing pre-movement planning (preplanning) of multiple sequence elements to reduce computational overhead during active movement. However, it is unclear which brain regions mediate preplanning or how this process evolves with learning. Recording cortico-basal ganglia field potentials during a multi-day typing task in four individuals with PD, we found evidence for network-wide multi-element preplanning that improved with learning, facilitated by functional connectivity. In both cortex and basal ganglia, pre-movement gamma (γ, 30–250 Hz) activity, historically linked to population spiking, distinguished between future action sequences and became increasingly predictive with learning. For motor cortex γ, this increase was tied to learning-related cross-frequency coupling led by cortically-driven network delta (δ, 0.5–4 Hz) synchrony. More generally, coordinated network δ supported a complex pattern of learning-driven cross-frequency couplings within and between cortex and basal ganglia, including striatal lead of cortical beta (β, 12–30 Hz) activity, reflecting the specialized roles of these brain regions in motor preparation. In contrast, impaired learning was characterized by practice-driven decreases in γ’s predictive value, limited cross-frequency coupling and absent network δ synchrony, with network dynamics possibly altered by pathologically high inter-basal ganglia δ synchrony. These results suggest that cortically-led δ phase coordination optimized cortico-basal ganglia multi-element preplanning through enhanced recruitment of higher-frequency neural activity. Neurostimulation that enhances cortico-basal ganglia δ synchrony may thus hold potential for improving skilled fine motor control in PD.
Open AccessMotor learning leverages coordinated low-frequency cortico-basal ganglia activity to optimize motor preparation in humans with Parkinson’s Disease
Learning dexterous motor sequences is crucial to autonomy and quality of life but can be altered in Parkinson’s Disease (PD). Learning involves optimizing pre-movement planning (preplanning) of multiple sequence elements to reduce computational overhead during active movement. However, it is unclear which brain regions mediate preplanning or how this process evolves with learning. Recording cortico-basal ganglia field potentials during a multi-day typing task in four individuals with PD, we found evidence for network-wide multi-element preplanning that improved with learning, facilitated by functional connectivity. In both cortex and basal ganglia, pre-movement gamma (γ, 30–250 Hz) activity, historically linked to population spiking, distinguished between future action sequences and became increasingly predictive with learning. For motor cortex γ, this increase was tied to learning-related cross-frequency coupling led by cortically-driven network delta (δ, 0.5–4 Hz) synchrony. More generally, coordinated network δ supported a complex pattern of learning-driven cross-frequency couplings within and between cortex and basal ganglia, including striatal lead of cortical beta (β, 12–30 Hz) activity, reflecting the specialized roles of these brain regions in motor preparation. In contrast, impaired learning was characterized by practice-driven decreases in γ’s predictive value, limited cross-frequency coupling and absent network δ synchrony, with network dynamics possibly altered by pathologically high inter-basal ganglia δ synchrony. These results suggest that cortically-led δ phase coordination optimized cortico-basal ganglia multi-element preplanning through enhanced recruitment of higher-frequency neural activity. Neurostimulation that enhances cortico-basal ganglia δ synchrony may thus hold potential for improving skilled fine motor control in PD.
- Open Access
- 3 July 2024
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 44 (32)
Human Cervical Epidural Spinal Electrogram Topographically Maps Distinct Volitional Movements
Little is known about the electrophysiologic activity of the intact human spinal cord during volitional movement. We analyzed epidural spinal recordings from a total of five human subjects of both sexes during a variety of upper extremity movements and found that these spinal epidural electrograms contain spectral information distinguishing periods of movement, rest, and sensation. Cervical epidural electrograms also contained spectral changes time-locked with movement. We found that these changes were primarily associated with increased power in the theta (4–8 Hz) band and feature increased theta phase to gamma amplitude coupling, and this increase in theta power can be used to topographically map distinct upper extremity movements onto the cervical spinal cord in accordance with established myotome maps of the upper extremity. Our findings have implications for the development of neurostimulation protocols and devices focused on motor rehabilitation for the upper extremity, and the approach presented here may facilitate spatiotemporal mapping of naturalistic movements.
- 3 July 2024
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 44 (32)
Open AccessHuman Cervical Epidural Spinal Electrogram Topographically Maps Distinct Volitional Movements
Little is known about the electrophysiologic activity of the intact human spinal cord during volitional movement. We analyzed epidural spinal recordings from a total of five human subjects of both sexes during a variety of upper extremity movements and found that these spinal epidural electrograms contain spectral information distinguishing periods of movement, rest, and sensation. Cervical epidural electrograms also contained spectral changes time-locked with movement. We found that these changes were primarily associated with increased power in the theta (4–8 Hz) band and feature increased theta phase to gamma amplitude coupling, and this increase in theta power can be used to topographically map distinct upper extremity movements onto the cervical spinal cord in accordance with established myotome maps of the upper extremity. Our findings have implications for the development of neurostimulation protocols and devices focused on motor rehabilitation for the upper extremity, and the approach presented here may facilitate spatiotemporal mapping of naturalistic movements.
- Open Access
- 10 November 2022
- Published by Society for Neuroscience in eneuro
- Vol. 9 (6)
Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral Signatures
The ability of humans to coordinate stereotyped, alternating movements between the two legs during bipedal walking is a complex motor behavior that requires precisely timed activities across multiple nodes of the supraspinal network. Understanding of the neural network dynamics that underlie natural walking in humans is limited. We investigated cortical and subthalamic neural activities during overground walking and evaluated spectral biomarkers to decode the gait cycle in three patients with Parkinson’s disease without gait disturbances. Patients were implanted with chronic bilateral deep brain stimulation (DBS) leads in the subthalamic nucleus (STN) and electrocorticography paddles overlaying the primary motor and somatosensory cortices. Local field potentials were recorded from these areas while the participants performed overground walking and synchronized to external gait kinematic sensors. We found that the STN displays increased low-frequency (4–12 Hz) spectral power during the period before contralateral leg swing. Furthermore, STN shows increased theta frequency (4–8 Hz) coherence with the primary motor through the initiation and early phase of contralateral leg swing. Additional analysis revealed that each patient had specific frequency bands that could detect a significant difference between left and right initial leg swing. Our findings indicate that there are alternating spectral changes between the two hemispheres in accordance with the gait cycle. In addition, we identified patient-specific, gait-related biomarkers in both the STN and cortical areas at discrete frequency bands that may be used to drive adaptive DBS to improve gait dysfunction in patients with Parkinson’s disease.
- 10 November 2022
- Published by Society for Neuroscience in eneuro
- Vol. 9 (6)
Open AccessCortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral Signatures
The ability of humans to coordinate stereotyped, alternating movements between the two legs during bipedal walking is a complex motor behavior that requires precisely timed activities across multiple nodes of the supraspinal network. Understanding of the neural network dynamics that underlie natural walking in humans is limited. We investigated cortical and subthalamic neural activities during overground walking and evaluated spectral biomarkers to decode the gait cycle in three patients with Parkinson’s disease without gait disturbances. Patients were implanted with chronic bilateral deep brain stimulation (DBS) leads in the subthalamic nucleus (STN) and electrocorticography paddles overlaying the primary motor and somatosensory cortices. Local field potentials were recorded from these areas while the participants performed overground walking and synchronized to external gait kinematic sensors. We found that the STN displays increased low-frequency (4–12 Hz) spectral power during the period before contralateral leg swing. Furthermore, STN shows increased theta frequency (4–8 Hz) coherence with the primary motor through the initiation and early phase of contralateral leg swing. Additional analysis revealed that each patient had specific frequency bands that could detect a significant difference between left and right initial leg swing. Our findings indicate that there are alternating spectral changes between the two hemispheres in accordance with the gait cycle. In addition, we identified patient-specific, gait-related biomarkers in both the STN and cortical areas at discrete frequency bands that may be used to drive adaptive DBS to improve gait dysfunction in patients with Parkinson’s disease.